Distinct spatiotemporal tumor-immune ecologies enable disease prediction in NSCLC patients

被引：0
|
作者：
Prabhakaran, Sandhya
Gatenbee, Chandler
Robertson-Tessi, Mark
Beg, Amer A.
Gray, Jhanelle
Antonia, Scott
Gatenby, Robert A.
Anderson, Alexander R. A.
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 10期
关键词：
D O I：
10.1158/1538-7445.EVODYN22-B020
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B020
引用
收藏
页数：2
相关论文
共 50 条
  • [21] XGBoost-based and tumor-immune characterized gene signature for the prediction of metastatic status in breast cancer
    Qingqing Li
    Hui Yang
    Peipei Wang
    Xiaocen Liu
    Kun Lv
    Mingquan Ye
    Journal of Translational Medicine, 20
  • [22] XGBoost-based and tumor-immune characterized gene signature for the prediction of metastatic status in breast cancer
    Li, Qingqing
    Yang, Hui
    Wang, Peipei
    Liu, Xiaocen
    Lv, Kun
    Ye, Mingquan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [23] Circulating immune cell phenotype dynamics reflect the strength of tumor-immune cell interactions in patients during immunotherapy
    Griffiths, Jason, I
    Wallet, Pierre
    Pflieger, Lance T.
    Stenehjem, David
    Liu, Xuan
    Cosgrove, Patrick A.
    Leggett, Neena A.
    McQuerry, Jasmine A.
    Shrestha, Gajendra
    Rossetti, Maura
    Sunga, Gemalene
    Moos, Philip J.
    Adler, Frederick R.
    Chang, Jeffrey T.
    Sharma, Sunil
    Bild, Andrea H.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (27) : 16072 - 16082
  • [24] Tumor-immune spatial interactions on NSCLC H&E slide images predicts immunotherapy response: Preliminary external validation
    Chung, L. I-Y.
    Li, H.
    Kim, L.
    Lee, S.
    Maghsoudi, O. Haji
    Hiremath, A.
    Lee, J.
    Kim, P. Haseok
    Lee, S.
    Yadav, M.
    Chuchuca, M. J. A.
    Um, T.
    Kim, Y.
    Hong, I.
    Kang, G.
    Cho, A.
    Cooper, L.
    Madabhushi, A.
    Braman, N.
    Chae, Y. K.
    ANNALS OF ONCOLOGY, 2024, 35 : S282 - S283
  • [25] Regulation of immune microenvironment may enable MET-altered NSCLC patients to benefit from immune checkpoint inhibitors
    Zhang, Chenyue
    Wang, Haiyong
    LUNG CANCER, 2021, 154 : 221 - 223
  • [26] The prognostic significance of tumor-immune microenvironment in ascites of patients with high-grade serous carcinoma
    Miceska, Simona
    Skof, Erik
    Bucek, Simon
    Kuhar, Cvetka Grasic
    Gasljevic, Gorana
    Smrkolj, Spela
    Prevodnik, Veronika Kloboves
    RADIOLOGY AND ONCOLOGY, 2023, 57 (04) : 493 - 506
  • [27] Lung Immune Prognostic Index for Outcome Prediction to Immunotherapy in Patients With NSCLC
    Xu, Zhijie
    Yan, Yuanliang
    Wang, Xiang
    Zeng, Shuangshuang
    Gong, Zhicheng
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (09) : E207 - E208
  • [28] SPATIAL-TRANSCRIPTOMIC ANALYSIS OF TUMOR-IMMUNE MICROENVIRONMENT IN AML PATIENTS RECEIVING PEMBROLIZUMAB AND DECITABINE
    Zhao, Chen
    Wong-Rolle, Abigail
    Divakar, Prajan
    Calvo, Katherine
    Hourigan, Christopher
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A270 - A270
  • [29] Exploring Tumor-Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients
    Jeong, So-Ra
    Kang, Minyong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [30] Distinct Immune Status in Patients with Adenocarcinoma and Squamous Cell Carcinoma: Implication for Immunotherapy of NSCLC
    Hradilova, N.
    Palata, O.
    Sadilova, L.
    Mysikova, D.
    Mrazkova, H.
    Lischke, R.
    Spisek, R.
    Adkins, I.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2423 - S2423
12345